Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| A | Tubulin_C | e6ws6A1 | A: a/b three-layered sandwiches | X: Immunoglobulin-like beta-sandwich | H: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | T: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | F: Tubulin_C | ECOD (v294.1) |
| C | Tubulin_C | e6ws6C1 | A: a/b three-layered sandwiches | X: Immunoglobulin-like beta-sandwich | H: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | T: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | F: Tubulin_C | ECOD (v294.1) |
| E | Tubulin_C | e6ws6E1 | A: a/b three-layered sandwiches | X: Immunoglobulin-like beta-sandwich | H: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | T: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | F: Tubulin_C | ECOD (v294.1) |
| B | Tubulin_C | e6ws6B1 | A: a/b three-layered sandwiches | X: Immunoglobulin-like beta-sandwich | H: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | T: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | F: Tubulin_C | ECOD (v294.1) |
| D | Tubulin_C | e6ws6D1 | A: a/b three-layered sandwiches | X: Immunoglobulin-like beta-sandwich | H: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | T: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | F: Tubulin_C | ECOD (v294.1) |
| F | Tubulin_C | e6ws6F1 | A: a/b three-layered sandwiches | X: Immunoglobulin-like beta-sandwich | H: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | T: Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases | F: Tubulin_C | ECOD (v294.1) |
Domain Annotation: CATH CATH Database Homepage
| Chain | Domain | Class | Architecture | Topology | Homology | Provenance Source (Version) |
|---|---|---|---|---|---|---|
| A | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
| C | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
| E | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
| B | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
| D | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
| F | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
IMGT Antibody Annotation IMGT Database Homepage
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|---|---|---|---|---|---|---|---|
| S309 Fab, anti-SARS-CoV-2, neutralizing | VH-CH1 | Homo sapiens (human) | IGHV1-18*01, IGHV1-18*04, IGHJ1*01, IGHG1*01, IGHG1*02, IGHG1*04, IGHG1*05, IGHG1*12, IGHG1*14, IGHG1*13, IGHG1*09, IGHG1*10, IGHG1*07, IGHG1*11 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202613-0) | |
| S309 Fab, anti-SARS-CoV-2, neutralizing | L-KAPPA | Homo sapiens (human) | IGKV3-20*01, IGKJ4*01, IGKJ4*02, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202613-0) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| Heavy Chain | IGHV1 | - | JEFFAMINE | SAbDab (2026-04-10) | |
| Light Chain | IGKV3 | Kappa | JEFFAMINE | SAbDab (2026-04-10) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| Sotrovimab | SARS-CoV-2 Spike RBD | Therapeutic SAbDab (2026-04-10) | |
| Sotrovimab | SARS-CoV-2 Spike RBD | Therapeutic SAbDab (2026-04-10) |














